AC
ETNB

Athanor Capital’s 89bio ETNB Stock Holding History

Athanor Capital’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,469
Closed -$426K – 888
2020
Q4 		$426K Buy
17,469
+9,551
+121% +$244K 0.01% 504
2020
Q3 		$203K Buy
+7,918
New +$251K 0.01% 491
2020
Q1 		– Sell
-10,696
Closed -$281K – 219
2019
Q4 		$281K Buy
+10,696
New +$298K 0.01% 319

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Athanor Capital's ETNB Position: Q1 2021 in Review

Athanor Capital sold out of 89bio (ETNB) in Q1 2021, closing a stake of 17,469 shares — an estimated $426K sold.

Athanor Capital first reported a position in ETNB in Q4 2019 and held it in 3 quarters. The position peaked at $426K in Q4 2020. 67 funds tracked by Wall St. Rank hold ETNB as of Q1 2021.

  • Athanor Capital reported no remaining 89bio position as of Q1 2021 after selling out during the quarter.
  • Athanor Capital sold 17,469 89bio shares in Q1 2021, an estimated $426K.
  • Athanor Capital first reported a position in 89bio in Q4 2019 and held it in 3 quarters.
  • Athanor Capital's 89bio position peaked at $426K in Q4 2020.
  • 67 funds tracked by Wall St. Rank held 89bio as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.